カテゴリ： Bahamas, GlobalData, 企業調査

Nymox Pharmaceutical Corp (NYMX)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Nymox Pharmaceutical Corp (NYMX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7373
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：68
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：Bahamas
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer’s disease. Its diagnostic product portfolio includes NicAlert test to determine smoking status; and TobacAlert home test to determine person’s level of exposure to tobacco products, including second hand smoke. Nymox’s lead drug candidate, NX-1207 intended for the treatment of BPH (benign prostatic hyperplasia) and certain types of cancer. It has subsidiaries in New Jersey, the US. Nymox is headquartered in Nassau, the Bahamas.

Nymox Pharmaceutical Corp (NYMX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Nymox Pharmaceutical Corp, Medical Equipment, Deal Details 14
Equity Offering 14
Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 14
Nymox Pharmaceutical to Raise USD12 Million in Private Placement 15
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 16
Nymox Pharma Raises USD0.59 Million in Private Placement of Shares 17
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 18
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 19
Nymox Pharma Raises USD0.25 Million in Private Placement of Shares 20
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 21
Nymox Pharma Raises USD0.15 million in Private Placement of Shares 22
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 23
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 24
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 25
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 26
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 27
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 28
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 29
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 30
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 31
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 32
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 33
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 34
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 35
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 36
Nymox Pharma Raises USD0.14 Million in Private Placement of Shares 37
Nymox Pharma Raises USD0.15 Million in Public Offering of Shares 38
Nymox Pharma Raises USD0.35 Million in Public Offering of Shares 39
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 40
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 41
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 42
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 43
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 44
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 45
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 46
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 47
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 48
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 49
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 50
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 51
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 52
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 53
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 54
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 55
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 56
Nymox Pharma Raises USD1.1 Million in Private Placement of Shares 57
Nymox Pharma Raises USD1 Million in Private Placement of Shares 58
Nymox Pharma Raises USD1 Million in Private Placement of Shares 59
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 60
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 61
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 62
Nymox Pharma Raises USD1 Million in Private Placement of Shares 63
Nymox Pharmaceutical Corp – Key Competitors 64
Nymox Pharmaceutical Corp – Key Employees 65
Nymox Pharmaceutical Corp – Locations And Subsidiaries 66
Head Office 66
Other Locations & Subsidiaries 66
Recent Developments 67
Other Significant Developments 67
Jul 02, 2018: NYMOX Announces Expanded Marketing Plans 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
Nymox Pharmaceutical Corp, Medical Equipment, Key Facts, 2017 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Nymox Pharmaceutical Corp, Deals By Market, 2012 to YTD 2018 10
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 14
Nymox Pharmaceutical to Raise USD12 Million in Private Placement 15
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 16
Nymox Pharma Raises USD0.59 Million in Private Placement of Shares 17
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 18
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 19
Nymox Pharma Raises USD0.25 Million in Private Placement of Shares 20
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 21
Nymox Pharma Raises USD0.15 million in Private Placement of Shares 22
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 23
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 24
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 25
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 26
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 27
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 28
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 29
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 30
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 31
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 32
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 33
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 34
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 35
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 36
Nymox Pharma Raises USD0.14 Million in Private Placement of Shares 37
Nymox Pharma Raises USD0.15 Million in Public Offering of Shares 38
Nymox Pharma Raises USD0.35 Million in Public Offering of Shares 39
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 40
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 41
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 42
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 43
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 44
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 45
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 46
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 47
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 48
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 49
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 50
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 51
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 52
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 53
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 54
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 55
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 56
Nymox Pharma Raises USD1.1 Million in Private Placement of Shares 57
Nymox Pharma Raises USD1 Million in Private Placement of Shares 58
Nymox Pharma Raises USD1 Million in Private Placement of Shares 59
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 60
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 61
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 62
Nymox Pharma Raises USD1 Million in Private Placement of Shares 63
Nymox Pharmaceutical Corp, Key Competitors 64
Nymox Pharmaceutical Corp, Key Employees 65
Nymox Pharmaceutical Corp, Subsidiaries 66

List of Figures
Nymox Pharmaceutical Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Nymox Pharmaceutical Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Nymox Pharmaceutical Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Nymox Pharmaceutical Corp (NYMX)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • CyberOptics Corp (CYBE)：企業の財務・戦略的SWOT分析
    Summary CyberOptics Corp (CyberOptics) is a technology company that offers high precision 3D sensors. The company’s products include SMT inspection, semiconductor and MRS sensors. CyberOptics SMT inspection provides solder paste inspection systems, automated optical inspection systems, and software …
  • Harvard Medical School-製薬・医療分野：企業M&A・提携分析
    Summary Harvard Medical School (HMS), a subsidiary of Harvard University is a medical institute that offers education, research and clinical care services. The institute offers various degree programs such as bachelor's program, master's program, PhD program, and continuing education. It offers prog …
  • XERIS Pharmaceuticals Inc (XERS)：製薬・医療：M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Glow Energy Public Co Ltd：発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Rhenovia Pharma Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Rhenovia Pharma Ltd (Rhenovia) is a biotechnology company that provides solutions for the treatment of Alzheimers disease and other central nervous system diseases. The company offers studies to academic research groups and industries based on biosimulation technology, which is a computation …
  • Real Matters Inc (REAL)：企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • TechnologyOne Ltd (TNE)：企業の財務・戦略的SWOT分析
    TechnologyOne Ltd (TNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bayerische Patentallianz GmbH-製薬・医療分野：企業M&A・提携分析
    Summary Bayerische Patentallianz GmbH (Bayerische Patentallianz) is a central patent and marketing agency that evaluates and markets the inventions, protecting, marketing and achieving financial benefits. The agency provides support and consulting services to small and medium businesses and free inv …
  • Entravision Communications Corp (EVC)：企業の財務・戦略的SWOT分析
    Entravision Communications Corp (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Immunodiagnostic Systems Holdings plc (IDH)：企業の財務・戦略的SWOT分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • National Oilwell Varco Inc (NOV)-石油・ガス分野：企業M&A・提携分析
    Summary National Oilwell Varco, Inc. (NOV) designs, manufactures and services a broad range of drilling and well servicing equipment and components for the oil and gas sector. Its offerings include rig systems, wellbore technologies, and completion and production technologies. Its product line compr …
  • Novo Nordisk AS (NOVO B)：企業の財務・戦略的SWOT分析
    Novo Nordisk AS (NOVO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • InsuLine Medical Ltd (INSL)-医療機器分野：企業M&A・提携分析
    Summary InsuLine Medical Ltd (InsuLine Medical) is a medical device company that develops, manufactures and markets device which enables patients on intensive insulin therapy. The company’s products include InsuPad and InsuPatch. Its InsuPad is a patch for syringes and insulin pens; and InsuPatch is …
  • Morinaga & Co., Ltd. (2201)：企業の財務・戦略的SWOT分析
    Morinaga & Co., Ltd. (2201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • OWC Pharmaceutical Research Corp (OWCP)：製薬・医療：M&Aディール及び事業提携情報
    Summary OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual solubl …
  • Avacta Group Plc (AVCT)：製品パイプライン分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • CAS Medical Systems Inc (CASM)-医療機器分野：企業M&A・提携分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers products such as FORE-SIGHT absolute tissue oximeter, blood pressure measurement technology, vital signs monitors and supplies for neonatal intens …
  • Mercury General Corporation：戦略・SWOT・企業財務分析
    Mercury General Corporation - Strategy, SWOT and Corporate Finance Report Summary Mercury General Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Thoresen Thai Agencies Public Company Limited：企業の戦略・SWOT・財務分析
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Capitol Federal Financial Inc：企業の戦略・SWOT・財務分析
    Capitol Federal Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Capitol Federal Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆